Warning letter
Central Imaging of Arlington: warning letter of Jun 7, 2001
FDA warning letter UCM069771 · Dallas District Office
Key facts
| Reference number | UCM069771 |
|---|---|
| Company | Central Imaging of Arlington |
| Subject | Mammography Quality Standards |
| Issue date | Jun 7, 2001 |
| Posted date | Jun 7, 2001 |
| Issuing office | Dallas District Office |
| Product type | Devices |
| Country | 3 |
| Inspection city | Arlington |
| Inspection ZIP | 76012-2513 |
| Inspection start date | May 30, 2001 |
| Letter on fda.gov | web.archive.org |
At a glance
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: